ENTBF
Price
$0.08
Change
+$0.01 (+14.29%)
Updated
Jun 27 closing price
Capitalization
1.01M
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 25 closing price
Capitalization
825.75K
40 days until earnings call
Interact to see
Advertisement

ENTBF vs SQZB

Header iconENTBF vs SQZB Comparison
Open Charts ENTBF vs SQZBBanner chart's image
ENTHEON BIOMEDICAL
Price$0.08
Change+$0.01 (+14.29%)
Volume$1K
Capitalization1.01M
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$100
Capitalization825.75K
ENTBF vs SQZB Comparison Chart in %
Loading...
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTBF vs. SQZB commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTBF is a Hold and SQZB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ENTBF: $0.08 vs. SQZB: $0.03)
Brand notoriety: ENTBF and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTBF: 60% vs. SQZB: 0%
Market capitalization -- ENTBF: $1.02M vs. SQZB: $825.75K
ENTBF [@Biotechnology] is valued at $1.02M. SQZB’s [@Biotechnology] market capitalization is $825.75K. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTBF’s FA Score shows that 0 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • ENTBF’s FA Score: 0 green, 5 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTBF is a better buy in the long-term than SQZB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTBF’s TA Score shows that 2 TA indicator(s) are bullish while SQZB’s TA Score has 1 bullish TA indicator(s).

  • ENTBF’s TA Score: 2 bullish, 6 bearish.
  • SQZB’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, ENTBF is a better buy in the short-term than SQZB.

Price Growth

ENTBF (@Biotechnology) experienced а +12.30% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

SQZB is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTBF($1.01M) has a higher market cap than SQZB($826K). SQZB YTD gains are higher at: -6.667 vs. ENTBF (-44.489).
ENTBFSQZBENTBF / SQZB
Capitalization1.01M826K122%
EBITDA-403.94KN/A-
Gain YTD-44.489-6.667667%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash525KN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ENTBFSQZB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HHH67.820.57
+0.85%
Howard Hughes Holdings
BBSI41.880.13
+0.30%
Barrett Business Services Inc.
AMPG2.09N/A
N/A
Amplitech Group
BIIB126.08-0.84
-0.66%
Biogen
LVO0.73-0.07
-8.78%
LiveOne

ENTBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTBF has been loosely correlated with SER. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTBF jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTBF
1D Price
Change %
ENTBF100%
+12.13%
SER - ENTBF
35%
Loosely correlated
+0.65%
IMRX - ENTBF
31%
Poorly correlated
+10.66%
XTLB - ENTBF
29%
Poorly correlated
N/A
GERN - ENTBF
27%
Poorly correlated
-3.27%
LABFF - ENTBF
20%
Poorly correlated
N/A
More

SQZB and

Correlation & Price change

A.I.dvisor tells us that SQZB and ATHA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SQZB and ATHA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
ATHA - SQZB
26%
Poorly correlated
-2.64%
OLMA - SQZB
13%
Poorly correlated
+1.32%
BRTX - SQZB
9%
Poorly correlated
-3.59%
BVAXF - SQZB
8%
Poorly correlated
N/A
ENTBF - SQZB
5%
Poorly correlated
+12.13%
More